Styrylquinazoline derivatives as ABL inhibitors selective for different DFG orientations

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Cancer Biology

Background:

• Quinazoline-based compounds are significant multi-target tyrosine kinase inhibitors.
• Previous research identified kinase inhibition activity in 4-aminostyrylquinazolines.

Purpose of the Study:

• Synthesize and evaluate a new series of styrylquinazolines with a C4 thioaryl moiety.
• Investigate their potential as multi-kinase inhibitors for cancer therapy.

Main Methods:

• Chemical synthesis of novel styrylquinazolines.
• In vitro kinase inhibition assays.
• Molecular docking studies targeting ABL kinase.
• Cellular assays to determine mechanism of action.
• Anticancer activity evaluation against leukemia.

Main Results:

• Several synthesized compounds exhibited high inhibition of non-receptor tyrosine kinases.
• Molecular docking revealed differential binding modes to ABL kinase conformational states.
• Compounds demonstrated sub-micromolar activity against leukemia cell lines.
• Cellular studies elucidated the mechanism of action for potent derivatives.

Conclusions:

• S4-substituted styrylquinazolines represent a promising scaffold for developing multi-kinase inhibitors.
• These compounds show potential as effective anticancer drugs targeting specific kinase binding modes.